Literature DB >> 12761657

Refined localization of dominant intermediate Charcot-Marie-Tooth neuropathy and exclusion of seven known candidate genes in the region.

Danqing Zhu1, Marina Kennerson, John Merory, Roman Chrast, Mark Verheijen, Greg Lemke, Garth Nicholson.   

Abstract

Charcot-Marie-Tooth (CMT) neuropathy is one of the most common hereditary disorders of the human peripheral nervous system. The CMT syndrome includes weakness and atrophy of distal muscles, high arched feet (pes cavus), depressed or absent deep tendon reflexes, and mild sensory loss. Dominant intermediate CMT (DI-CMT) neuropathy is a form of CMT with intermediate median motor nerve conduction velocities. We previously localized the DI-CMT locus to a 16.8-cM region on chromosome 19p12-p13.2. Extended haplotype analysis and clinical assessment of additional family members and a report of a second family linked to this locus has enabled us to narrow the candidate region to a 6-cM interval flanked by D19S558 and D19S432. Selection of positional candidate genes for screening was performed on the basis of neural expression and microarray analysis of Schwann cell differentiation in vivo. Seven candidate genes have been investigated. These include six genes localized in the original linkage interval and one in the newly refined region. They are excluded as a cause for DI-CMT neuropathy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12761657     DOI: 10.1007/s10048-003-0147-y

Source DB:  PubMed          Journal:  Neurogenetics        ISSN: 1364-6745            Impact factor:   2.660


  27 in total

Review 1.  Molecular genetics of inherited peripheral neuropathies: who are the actors?

Authors:  J Meuleman; V Timmerman; E Nelis; P De Jonghe
Journal:  Acta Neurol Belg       Date:  2000-09       Impact factor: 2.396

2.  A 3-Mb region for the familial hemiplegic migraine locus on 19p13.1-p13.2: exclusion of PRKCSH as a candidate gene. Dutch Migraine Genetic Research Group.

Authors:  R A Ophoff; G M Terwindt; M N Vergouwe; R van Eijk; H Mohrenweiser; M Litt; M H Hofker; J Haan; M D Ferrari; R R Frants
Journal:  Eur J Hum Genet       Date:  1996       Impact factor: 4.246

3.  Assignment of the human alpha-tropomyosin gene TPM4 to band 19p13.1 by fluorescence in situ hybridization.

Authors:  S D Wilton; L Lim; S D Dorosz; H C Gunn; H J Eyre; D F Callen; N G Laing
Journal:  Cytogenet Cell Genet       Date:  1996

Review 4.  Molecular cell biology of Charcot-Marie-Tooth disease.

Authors:  Philipp Berger; Peter Young; Ueli Suter
Journal:  Neurogenetics       Date:  2002-03       Impact factor: 2.660

5.  Growth and early postimplantation defects in mice deficient for the bromodomain-containing protein Brd4.

Authors:  Denis Houzelstein; Simon L Bullock; Denise E Lynch; Elena F Grigorieva; Valerie A Wilson; Rosa S P Beddington
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

6.  Charcot-Marie-Tooth disease type 2A caused by mutation in a microtubule motor KIF1Bbeta.

Authors:  C Zhao; J Takita; Y Tanaka; M Setou; T Nakagawa; S Takeda; H W Yang; S Terada; T Nakata; Y Takei; M Saito; S Tsuji; Y Hayashi; N Hirokawa
Journal:  Cell       Date:  2001-06-01       Impact factor: 41.582

7.  Mutations in the early growth response 2 (EGR2) gene are associated with hereditary myelinopathies.

Authors:  L E Warner; P Mancias; I J Butler; C M McDonald; L Keppen; K G Koob; J R Lupski
Journal:  Nat Genet       Date:  1998-04       Impact factor: 38.330

8.  Mutation of the myelin P0 gene in Charcot-Marie-Tooth neuropathy type 1B.

Authors:  K Hayasaka; G Takada; V V Ionasescu
Journal:  Hum Mol Genet       Date:  1993-09       Impact factor: 6.150

9.  Mutations in the small GTP-ase late endosomal protein RAB7 cause Charcot-Marie-Tooth type 2B neuropathy.

Authors:  Kristien Verhoeven; Peter De Jonghe; Katrien Coen; Nathalie Verpoorten; Michaela Auer-Grumbach; Jennifer M Kwon; David FitzPatrick; Eric Schmedding; Els De Vriendt; An Jacobs; Veerle Van Gerwen; Klaus Wagner; Hans-Peter Hartung; Vincent Timmerman
Journal:  Am J Hum Genet       Date:  2003-01-21       Impact factor: 11.025

10.  The clinical features of hereditary motor and sensory neuropathy types I and II.

Authors:  A E Harding; P K Thomas
Journal:  Brain       Date:  1980-06       Impact factor: 13.501

View more
  3 in total

Review 1.  Intermediate forms of Charcot-Marie-Tooth neuropathy: a review.

Authors:  Garth Nicholson; Simon Myers
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

Review 2.  Intermediate Charcot-Marie-Tooth disease: an electrophysiological reappraisal and systematic review.

Authors:  José Berciano; Antonio García; Elena Gallardo; Kristien Peeters; Ana L Pelayo-Negro; Silvia Álvarez-Paradelo; José Gazulla; Miriam Martínez-Tames; Jon Infante; Albena Jordanova
Journal:  J Neurol       Date:  2017-03-31       Impact factor: 4.849

3.  A rapid and reliable detection system for the analysis of PMP22 gene dosage by MP/DHPLC assay.

Authors:  Chia-Yun Lin; Yi-Ning Su; Chien-Nan Lee; Chia-Cheng Hung; Wen-Fang Cheng; Win-Li Lin; Chi-An Chen; Sung-Tsang Hsieh
Journal:  J Hum Genet       Date:  2006-02-04       Impact factor: 3.172

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.